Publications (1)2.17 Total impact
-
Article: Prolonged paradoxical response to anti-tuberculous treatment after infliximab.
[show abstract] [hide abstract]
ABSTRACT: A 56-year-old woman with ankylosing spondylitis, treated for 3 months with infliximab, developed miliary tuberculosis with mediastinal lymphadenopathies and brain and splenic lesions. After initial improvement under anti-tuberculous therapy, she suffered an unexpectedly prolonged paradoxical worsening with several episodes of lymphadenopathy, including life-threatening ones, over a period of more than 14 months of follow-up. The outcome was favorable as a result of corticosteroid and surgical treatments. This phenomenon reflects a paradoxical reaction precipitated by infliximab withdrawal.International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 09/2010; 14 Suppl 3:e333-4. · 2.17 Impact Factor
